Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration

We conducted a multicenter study of the safety, tolerability, and plasma pharmacokinetics of the parenteral formulation of voriconazole in immunocompromised pediatric patients (2 to 11 years old). Single doses of 3 or 4 mg/kg of body weight were administered to six and five children, respectively. I...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Walsh, Thomas J., Karlsson, Mats O., Driscoll, Timothy, Arguedas, Adriano G., Adamson, Peter, Saez-Llorens, Xavier, Vora, Ajay J., Arrieta, Antonio C., Blumer, Jeffrey, Lutsar, Irja, Milligan, Peter, Wood, Nolan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2004
Aiheet:
Clinical Therapeutics
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415618/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15155217/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.6.2166-2172.2004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia